Intraarterial high-dose cisplatinum (IAHDP) as a part of the treatment of relapsed or locally advanced tumors of the head and neck (H&N): A feasibility study.

e16000 Background: IAHDP has been employed as a part of the treatment of relapsed or locally advanced HN age 37-77 y, median 56 y- were treated (10 Hu0026N epidermoid carcinomas, 1 orbitary mts of adenocarcinoma of unknown origin). A total of 50 cycles were administered (2-9 per pt, median 4). In 4 pts IAHDP ...